Catalyst Event
Abbott Laboratories (ABT) · Earnings Release
From KEDI Global Obesity Care Industry Top 2+ Index (OBCI)
7/16/2026, 12:00:00 AM
Abbott's Q2 2026 earnings release is scheduled for July 16, 2026. Analysts forecast EPS of $1.28. Medium importance estimated as earnings typically drive >5% price movement expected.
Korean Translation
2026년 7월 16일 애보트의 2026년 2분기 실적 발표 예정임. 분석가들은 EPS 1.28달러를 전망함. 실적 발표는 통상 5% 이상의 주가 변동을 유발하므로 중간 중요도로 예상됨.
Related Recent Events
DICK'S Sporting Goods Inc (DKS) · Other
Quarterly cash dividend of $1.25 per share has an ex-dividend date of June 12, 2026. The dividend is scheduled to be paid on June 26, 2026.
6/12/2026, 12:00:00 AM
Novo Nordisk A/S (NVO) · Other
New Phase 3 data for the pipeline drug CagriSema to be presented at the American Diabetes Association (ADA) Scientific Sessions on June 7, 2026, with a low price impact scheduled.
6/7/2026, 12:00:00 AM
Lululemon Athletica Inc (LULU) · Earnings Release
Lululemon Athletica is scheduled to release its financial results for the first quarter of fiscal 2026 on June 4, 2026, after the market closes. High importance is estimated as earnings releases typically result in significant price volatility. scheduled
6/4/2026, 12:00:00 AM
Life Time Group Holdings Inc (LTH) · Other
RBC Capital analysts forecast a price target of $43.00 for Life Time Group Holdings on June 2, 2026; target increases typically suggest a low positive impact, forecasted.
6/2/2026, 12:00:00 AM
Astrazeneca PLC (AZN) · Other
Positive results from the EMERALD-3 Phase III trial were presented at the ASCO 2026 meeting on 2026-06-01, showing that Imfinzi and Imjudo combined with lenvatinib and TACE reduced the risk of disease progression or death by 30% in patients with unresectable liver cancer; high market impact (>=10%) expected due to significant clinical efficacy.
6/1/2026, 12:00:00 AM
Amgen Inc (AMGN) · Other
The European Commission granted marketing authorization for IMDYLLTRA® (tarlatamab) on 2026-06-01 for the treatment of ES-SCLC; expected to have a medium market impact of approximately 5% due to expanded market access.
6/1/2026, 12:00:00 AM